About Thomas Goodrich II
Form D filings for TIXiMED in 2024 list Thomas Goodrich II as president and director.
Thomas Goodrich II first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Goodrich II in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thomas Goodrich II works with at each company, as listed on that company's latest Form D.
TIXiMED, Inc. · Form D, Nov 5, 2024
AS
Aneth Shalev
Director